[The therapy of polycythemia vera].
D000477:Alkylating Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001815:Bloodletting; D002066:Busulfan / Q000009:adverse effects / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D010759:Phosphorus Isotopes / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000188:drug therapy / Q000628:therapy*
D000477:Alkylating Agents; D000925:Anticoagulants; D006634:Histamine H1 Antagonists; D010759:Phosphorus Isotopes; D002699:Chlorambucil; D002066:Busulfan
Die Therapie der Polycythaemia vera.